Follow
Chintan H. Kapadia
Title
Cited by
Cited by
Year
Spherical nucleic acid nanoparticles: therapeutic potential
CH Kapadia, JR Melamed, ES Day
BioDrugs 32 (4), 297-309, 2018
1082018
Nanoparticulate immunotherapy for cancer
CH Kapadia, JL Perry, S Tian, JC Luft, JM DeSimone
Journal of Controlled Release 219, 167-180, 2015
982015
Layer‐by‐layer assembled PLGA nanoparticles carrying miR‐34a cargo inhibit the proliferation and cell cycle progression of triple‐negative breast cancer cells
CH Kapadia, SA Ioele, ES Day
Journal of biomedical materials research Part A 108 (3), 601-613, 2020
462020
Pulmonary delivery of nanoparticle-bound toll-like receptor 9 agonist for the treatment of metastatic lung cancer
JL Perry, S Tian, N Sengottuvel, EB Harrison, BK Gorentla, CH Kapadia, ...
ACS nano 14 (6), 7200-7215, 2020
452020
Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity
JM Caster, M Sethi, S Kowalczyk, E Wang, X Tian, SN Hyder, KT Wagner, ...
Nanoscale 7 (6), 2805-2811, 2015
442015
Reduction sensitive PEG hydrogels for codelivery of antigen and adjuvant to induce potent CTLs
CH Kapadia, S Tian, JL Perry, JC Luft, JM DeSimone
Molecular pharmaceutics 13 (10), 3381-3394, 2016
412016
Polymer nanocarriers for MicroRNA delivery
CH Kapadia, B Luo, MN Dang, ND Irvin‐Choy, DM Valcourt, ES Day
Journal of applied polymer science 137 (25), 48651, 2020
402020
Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a
R Goyal, CH Kapadia, JR Melamed, RS Riley, ES Day
Cellular and molecular bioengineering 11, 383-396, 2018
342018
Extending antigen release from particulate vaccines results in enhanced antitumor immune response
CH Kapadia, S Tian, JL Perry, D Sailer, JC Luft, JM DeSimone
Journal of Controlled Release 269, 393-404, 2018
312018
Role of linker length and antigen density in nanoparticle peptide vaccine
CH Kapadia, S Tian, JL Perry, JC Luft, JM DeSimone
ACS omega 4 (3), 5547-5555, 2019
272019
Best practices for preclinical in vivo testing of cancer nanomedicines
DM Valcourt, CH Kapadia, MA Scully, MN Dang, ES Day
Advanced healthcare materials 9 (12), 2000110, 2020
202020
Quantification of Gold Nanoparticles Using the NanoDrop One Microvolume UV-Vis Spectrophotometer
CH Kapadia, JR Melamed, ES Day
Thermo Fisher Scientific: Waltham, MA, USA, 2019
32019
Nanotargeting to the kidney
RM Williams, C Kapadia, EA Jaimes, DA Heller
Regenerative Nephrology, 439-449, 2022
22022
Efficacy and Adverse Effects of a Novel Mesoscale Nanoparticle-Guided Sirolimus Delivery Strategy in a Pkhd1PCK Rat Model: PO1227
M Mrug, DA Heller, CH Kapadia, R Williams, PH Chumley, S Mullen, ...
Journal of the American Society of Nephrology 32 (10S), 398, 2021
22021
Rapamycin-encapsulated nanoparticle delivery in polycystic kidney disease mice
S Yamaguchi, R Sedaka, C Kapadia, J Huang, JS Hsu, TF Berryhill, ...
Scientific Reports 14 (1), 15140, 2024
2024
Toll-like receptor agonist modified particles and their use in lung cancer
TR Joseph M. Desimone, Jillian PERRY, Chintan KAPADIA, Shaomin TIAN, James ...
WO Patent WO/2018/207,153, 2018
2018
Engineering print® nanoparticle subunit vaccine to induce antitumor immune response
CH Kapadia
The University of North Carolina at Chapel Hill, 2016
2016
Particles that enhance immune responses by increasing cytotoxic t-cell function or production of interferon gamma therefrom
JP Joseph Desimone, Chintan KAPADIA, Shaomin TIAN
US Patent WO2015153632A1, 2015
2015
Nanoparticle chemosensitization
M Sethi, S Kowalczyk, E Wang, C Kapadia, A Wang
International Journal of Radiation Oncology, Biology, Physics 87 (2), S648-S649, 2013
2013
P4‐030: Elevated Amyloid‐beta Impairs Protein Sumoylation
L Lee, E Dale, A Staniszewski, H Zhang, F Michelassi, M Sakurai, ...
Alzheimer's & Dementia 6, e29-e29, 2010
2010
The system can't perform the operation now. Try again later.
Articles 1–20